Edesa Biotech Inc. (NASDAQ: EDSA) shares are trading higher Tuesday after the company announced additional results from the Phase 2 part of the ongoing Phase 2/3 study of EB05 in COVID-19. The stock saw a large gap up early Tuesday and has been fading back down since.